Editas Medicine (EDIT) Current Assets (2015 - 2025)

Editas Medicine (EDIT) has 11 years of Current Assets data on file, last reported at $163.9 million in Q4 2025.

• Quarterly Current Assets fell 43.35% year-over-year to $163.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $163.9 million (down 43.35% YoY) and the FY2025 annual result came in at $163.9 million, down 43.35% from the prior year.
• Current Assets slipped to $163.9 million in Q4 2025 per EDIT's latest filing, from $176.9 million in the prior quarter.
• Across five years, Current Assets topped out at $632.3 million in Q1 2021 and bottomed at $163.9 million in Q4 2025.
• The 5-year median for Current Assets is $348.8 million (2022), against an average of $371.5 million.
• The widest annual swing landed in 2021, when Current Assets surged 48.74%; it then slumped 43.35% in 2025.
• Tracing EDIT's Current Assets over 5 years: stood at $507.3 million in 2021, then fell by 29.68% to $356.8 million in 2022, then declined by 4.46% to $340.8 million in 2023, then decreased by 15.11% to $289.3 million in 2024, then tumbled by 43.35% to $163.9 million in 2025.
• Per Business Quant, the three latest EDIT Current Assets figures stand at $163.9 million (Q4 2025), $176.9 million (Q3 2025), and $182.8 million (Q2 2025).

Peer Comparison